Butterfly Network Adds Two Executives to its Management Team

Butterfly Network Inc. has welcomed two new members to its C-Suite.

The firm recently appointed Tamara Dillon as chief People Officer (CPO) and Larry Weiss as chief Legal Officer and Corporate Secretary, effective May 23.
 
“The addition of Tamara and Larry brings two extraordinary leaders with great depth of experience working within public companies, scaling talent, and respectively building and leading teams and functions to support growth,” said Dr. Todd Fruchterman, Butterfly Network’s president and CEO. “As we continue to execute on our strategy, expand the value we bring to global healthcare, and deliver upon our commitment to make Butterfly one of the most valuable and essential clinical assessment tools for medical professionals and the patients in their care, the roles of Chief People Officer and Chief Legal Officer are foundational to our organization. I look forward to working with and alongside Tamara and Larry in their new roles with Butterfly.”
 
Dillon joins Butterfly from Akebia Therapeutics, where she was senior vice president of Human Resources and chief People Officer. During her almost eight years at Akebia she played an integral role in scaling the company and was instrumental in developing talent and culture. She also led the company’s Diversity, Equity and Inclusion, and Patient Advocacy functions. Before Akebia, Dillon was in charge of Human Resources, Global Discovery Chemistry at Novartis Institutes for BioMedical Research, where she was responsible for all aspects of human resources. She also held several key roles at Genzyme, a Sanofi company.

“I look forward to joining the Butterfly team and supporting its commitment to democratize healthcare through innovation and enabling more informed healthcare decisions,” Dillon said. “The people organization is the heartbeat to any healthy company, especially one with the important goal of benefiting patients around the world. I’m excited and proud to step into this role and be part of the Butterfly team.”    
 
Weiss brings nearly 30 years of experience as an attorney, including 20 years in the medical device industry with Medtronic, Covidien, and Tyco Healthcare. Most recently, he served as chief Legal Officer for Emulate, a venture capital backed life sciences startup and as general counsel and corporate secretary of Analog Devices, a publicly traded semiconductor company. 
 
“I am excited to be a part of the next chapter of growth and evolution at Butterfly. I’m extremely motivated by Butterfly’s mission to make medical imaging available to everyone in the world, enabling more informed care decisions at the bedside. Butterfly is pursuing a goal that is both important and transformative; I am honored to come aboard and be part of the talented Butterfly team,” Weiss said. 
 
Founded by Dr. Jonathan Rothberg in 2011, Butterfly created the world’s first handheld, single probe whole-body ultrasound system using semiconductor technology, the Butterfly iQ+. Through its proprietary Ultrasound-on-Chip technology, Butterfly is developing earlier detection solutions and remote management of health conditions. The Butterfly iQ+ is available in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Sweden, Switzerland, and the United Kingdom. Butterfly iQ+ is a prescription device intended for trained healthcare professionals only.